Ignite Creation Date:
2024-05-06 @ 12:41 AM
Last Modification Date:
2024-10-26 @ 10:53 AM
Study NCT ID:
NCT01635400
Status:
UNKNOWN
Last Update Posted:
2012-07-09
First Post:
2012-06-27
Brief Title:
Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer
Sponsor:
Zhejiang Cancer Hospital
Organization:
Zhejiang Cancer Hospital
Study Overview
Official Title:
Phase Ⅱ Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer
Status:
UNKNOWN
Status Verified Date:
2012-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find out the correlation between uridine diphosphate glucuronosyl transferase 1A1UGT1A1 gene polymorphisms and the side effect and efficacy of irinotecan in patients with small cell lung cancer
Detailed Description:
In multiple studies of metastatic colorectal canceruridine diphosphate glucuronosyl transferase 1A1UGT1A1 gene polymorphisms and its correlation with irinotecan-associated side effects have been confirmedData from several studies indicated an improved clinical outcome of patients who had received an irinotecan-based regimenIn order to find out the correlation between UGT1A1 gene polymorphisms and the side effect and efficacy of irinotecan in patients with small cell lung cancerwe designed this study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None